SEC Form 4 · accession 0001209191-15-056934
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gerald Chan
Director
Period of report
Apr 14, 2015
Accepted (ET)
Jun 26, 2015 · 8:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $17.00 | Apr 14, 2015 | A | 20,000 | A | — | Apr 13, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The shares subject to the Option vest in 12 equal monthly installments from the vesting commencement date of March 30, 2015.